NYON, Switzerland–(BUSINESS WIRE)–Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with […]
Author: Ken Dropiewski
Reflow Medical Completes Enrollment in the DEEPER REVEAL Clinical Trial
May 09, 2024 07:00 AM Eastern Daylight Time SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces completion of enrollment in the DEEPER REVEAL clinical trial (NCT05358353) to evaluate the Reflow Spur™ Stent. Designated a Breakthrough Device by the FDA, the Spur is a […]
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update
PONTE VEDRA, Fla., May 9, 2024 /PRNewswire/ — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood clots in…
A major advance on stroke at Montpellier University Hospital published in the New England Journal of Medicine
Coordinated by Montpellier University Medical Center, France, the international study IN EXTREMIS-LASTE, representing a groundbreaking contribution to stroke research was published today in the New England Journal of Medicine. MONTPELLIER, France, May 9, 2024 /PRNewswire/ — “LASTE”…
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the first time that coronary CTA (CCTA) with fractional flow reserve (FFRCT) care significantly reduces mortality by over 60 percent at five years in patients with PAD undergoing […]
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 8, 2024 at 7:30 AM EDT PDF Version Data Support Advancement to Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 Full Data from the Phase 1 Study to be Presented at a Medical Congress in 2H 2024 SOUTH SAN FRANCISCO, Calif., May […]
Vivalink Launches Turnkey Ambulatory Cardiac Monitoring Solution for MCT and Holter
Empowering healthcare partners to streamline the delivery of cardiac monitoring services on an integrated technology solution Campbell, Calif. – May 8, 2024 – With cardiovascular disease being a leading cause of mortality worldwide, Vivalink, a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution […]
Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System
New CARTO™ 3 System Version 8 software introduces machine learning capabilities Increases efficiency, reproducibility, and accuracyi in the electro-anatomical maps electrophysiologists use in catheter ablation procedures Irvine, CA – May 8, 2024 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center hosts international conference on complex cardiac arrhythmias
AUSTIN, Texas, May 8, 2024 /PRNewswire/ — On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year’s event included 1,000 registered attendees from all over…
Recent
Solaris Endovascular Receives FDA Breakthrough Device Designation for Solaris DE™, a new Drug-Eluting Covered Stent
Embolization, Inc., Presents Novel Polymer-Based Coil at GEST, Booth No. 403
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
Popular
- No commented posts yet